FEV1Q as a Predictive Metric for Asthma Outcomes D Betancor; JM Olaguibel; V del Pozo; MJ Alvarez Puebla; E Arismendi; B Barroso; I Bobolea; B Cárdaba; JA Cañas; J Domínguez-Ortega; MJ Cruz; E Curto; A Garcia de la Fuente; FJ González-Barcala; JA Luna-Porta; C Martínez-Rivera; J Mullol; X Muñoz; C Picado; V Plaza; S Quirce; MJ Rial; L Soto-Retes; M Valverde-Monge; I Mahíllo-Fernández; J Sastre;

Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;

The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy María Florencia Pilia; María Jesús Cruz; Donghai Ma; Christian Romero-Mesones; David Espejo; Amaia Ojanguren; María Antonia Ramon; Xavier Muñoz; Iñigo Ojanguren;